HCS Pharma expects 90% success rate on Cancer drugs tests due to recreation of organs in-vitro with BIOMIMESYS® technology Results of new technique are a boost to Cancer research and a huge progress leap in comparison to current 2D technologies that generate 90% failuresParis, 8 March 2022 - Cancer is the s.